Drug allergy passport and other documentation for patients with drug hypersensitivity - An ENDA/EAACI Drug Allergy Interest Group Position Paper.
about
The importance of risk communication and documentation for patients with cutaneous adverse drug reactions.An EAACI task force report: recognising the potential of the primary care physician in the diagnosis and management of drug hypersensitivity.NSAID hypersensitivity – recommendations for diagnostic work up and patient management.
P2860
Drug allergy passport and other documentation for patients with drug hypersensitivity - An ENDA/EAACI Drug Allergy Interest Group Position Paper.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Drug allergy passport and othe ...... Interest Group Position Paper.
@en
type
label
Drug allergy passport and othe ...... Interest Group Position Paper.
@en
prefLabel
Drug allergy passport and othe ...... Interest Group Position Paper.
@en
P2093
P2860
P50
P356
P1433
P1476
Drug allergy passport and othe ...... Interest Group Position Paper.
@en
P2093
A Nakonechna
B Schnyder
G Calogiuri
P2860
P304
P356
10.1111/ALL.12929
P577
2016-05-04T00:00:00Z